HBM Holdings (FRA:6XY) Current Deferred Taxes Liabilities: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6XY HBM Holdings Ltd FRA:6XY
82 GF Score
Price €1.48
GF Value €1.34
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is HBM Holdings Current Deferred Taxes Liabilities?

HBM Holdings FRA:6XY +5.71% 82 Current Deferred Taxes Liabilities is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:6XY with a GF Score™ of 82/100 and a GF Value™ of €1.34 (Fairly Valued). The stock has 4 warning signs investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

HBM Holdings's current deferred tax liabilities for the quarter that ended in Jun. 2026 was €0.0 Mil.

HBM Holdings Current Deferred Taxes Liabilities Related Terms

HBM Holdings Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for HBM Holdings's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HBM Holdings Current Deferred Taxes Liabilities Chart

HBM Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

HBM Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:6XY
82GF Score
HBM Holdings Ltd FRA:6XY
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of €0.0 Mil mean?
HBM Holdings (FRA:6XY) has a Current Deferred Taxes Liabilities of €0.0 Mil as of Jun. 2026. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on HBM Holdings and its competitors.
Is HBM Holdings' Current Deferred Taxes Liabilities too high?
HBM Holdings' current Current Deferred Taxes Liabilities is €0.0 Mil. Overall, HBM Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HBM Holdings' Current Deferred Taxes Liabilities compare to VRTX and REGN?
HBM Holdings' Current Deferred Taxes Liabilities of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Biotechnology company?
A good Current Deferred Taxes Liabilities depends on the Biotechnology industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on HBM Holdings and its competitors. HBM Holdings's current Current Deferred Taxes Liabilities is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Holdings stock overvalued right now?
Based on GuruFocus' analysis, HBM Holdings (FRA:6XY) is currently considered Fairly Valued. The stock's GF Value™ is €1.34, compared to a current price of €1.48 — trading 10.4% above its estimated fair value. The current Current Deferred Taxes Liabilities is €0.0 Mil. HBM Holdings' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For HBM Holdings (FRA:6XY), the current Current Deferred Taxes Liabilities is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HBM Holdings (FRA:6XY) Overvalued in 2026?

Based on GuruFocus' analysis, HBM Holdings stock appears to be overvalued. The current stock price of €1.48 is trading 10.4% above its estimated GF Value™ of €1.34. GuruFocus considers HBM Holdings to be Fairly Valued.

Key valuation signals for FRA:6XY:

  • Current Deferred Taxes Liabilities: €0.0 Mil
  • GF Value™: €1.34 vs. price of €1.48 (10.4% above fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the FRA:6XY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HBM Holdings Business Description

Other Exchanges 02142:Hong Kong
Address No. 388 Fenglin Road, 6th Floor, Tower B, Fenglin International Phase I, Xuhui District, Shanghai, CHN, 200032
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the Europe.
82GF Score

Get the complete analysis for FRA:6XY

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.48
Price
€1.34
GF Value